FAVIPIRAVIR THERAPY FOR PATIENTS WITH COVID-19 PNEUMONIA: AN OBSERVATIONAL STUDY: Supawadee Suppadungsuk1 , Thananya Wongsinin1 , Sirawat Srichatrapimuk1 , Suppachok Kirdlarp1,2, Kulapong Jayanama1 , Kanin Thammavaranucupt1 , Dhanesh Pitidhammabhorn1 , Sithakom Phusanti1 , Nithita Nanthatanti1 and Somnuek Sungkanuparph1. SEATROPH. 2021;52(1):161-174. Accessed April 16, 2026. https://journal.seameotropmednetwork.org/index.php/jtropmed/article/view/429